BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 10606365)

  • 1. A computer based intervention to reduce unnecessary serologic testing.
    Solomon DH; Shmerling RH; Schur PH; Lew R; Fiskio J; Bates DW
    J Rheumatol; 1999 Dec; 26(12):2578-84. PubMed ID: 10606365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antinuclear antibody testing. A study of clinical utility.
    Slater CA; Davis RB; Shmerling RH
    Arch Intern Med; 1996 Jul; 156(13):1421-5. PubMed ID: 8678710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory tests for rheumatic diseases. When are they useful?
    Callegari PE; Williams WV
    Postgrad Med; 1995 Apr; 97(4):65-8, 71-4. PubMed ID: 7716093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How useful is the rheumatoid factor? An analysis of sensitivity, specificity, and predictive value.
    Shmerling RH; Delbanco TL
    Arch Intern Med; 1992 Dec; 152(12):2417-20. PubMed ID: 1456851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Avoiding laboratory test misinterpretation in geriatric rheumatology.
    Wernick R
    Geriatrics; 1989 Feb; 44(2):61-3, 67-8, 73-8 passim. PubMed ID: 2644158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization and predictive value of laboratory tests in patients referred to rheumatologists by primary care physicians.
    Suarez-Almazor ME; Gonzalez-Lopez L; Gamez-Nava JI; Belseck E; Kendall CJ; Davis P
    J Rheumatol; 1998 Oct; 25(10):1980-5. PubMed ID: 9779854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
    Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
    Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical utility of a positive antinuclear antibody test result.
    Abeles AM; Abeles M
    Am J Med; 2013 Apr; 126(4):342-8. PubMed ID: 23395534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The current use and interpretation of rheumatologic tests.
    Moder KG; Mason TG
    Adolesc Med; 1998 Feb; 9(1):25-34, v. PubMed ID: 10961249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recent advances in immunologic laboratory testing for rheumatic diseases].
    Akahoshi T
    Rinsho Byori; 2004 Sep; 52(9):743-50. PubMed ID: 15552934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why is the ANA result positive?
    Illei GG; Klippel JH
    Bull Rheum Dis; 1999 Jan; 48(1):1-4. PubMed ID: 10028188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative studies on the sensitivity, value and reliability of serologic rheumatism tests].
    Schmidt K; Mueller-Eckhardt C; Beckmann D
    Z Rheumaforsch; 1970; 29(1):20-6. PubMed ID: 5310250
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessment of education and computerized decision support interventions for improving transfusion practice.
    Rothschild JM; McGurk S; Honour M; Lu L; McClendon AA; Srivastava P; Churchill WH; Kaufman RM; Avorn J; Cook EF; Bates DW
    Transfusion; 2007 Feb; 47(2):228-39. PubMed ID: 17302768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Judicious use of biological tests in rheumatology].
    Aeschlimann A; Müller W
    Schweiz Rundsch Med Prax; 1991 Nov; 80(47):1312-7. PubMed ID: 1957096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis].
    Us D; Gülmez D; Hasçelik G
    Mikrobiyol Bul; 2003; 37(2-3):163-70. PubMed ID: 14593899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-CCP2 is an adjunct to, not a surrogate for, rheumatoid factor in the diagnosis of rheumatoid arthritis: diagnostic utility of anti-CCP2 antibodies in Egyptian patients with rheumatoid arthritis.
    Abdel-Nasser AM; Mahmoud MH; El Mansoury TM; Osman AM
    Scand J Rheumatol; 2008; 37(5):329-36. PubMed ID: 18666028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory testing in the rheumatic diseases: a practical review.
    Colglazier CL; Sutej PG
    South Med J; 2005 Feb; 98(2):185-91. PubMed ID: 15759949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing.
    Solomon DH; Kavanaugh AJ; Schur PH;
    Arthritis Rheum; 2002 Aug; 47(4):434-44. PubMed ID: 12209492
    [No Abstract]   [Full Text] [Related]  

  • 19. Measurement of antinuclear antibodies by multiplex immunoassay: a prospective, multicenter clinical evaluation.
    Moder KG; Wener MH; Weisman MH; Ishimori ML; Wallace DJ; Buckeridge DL; Homburger HA
    J Rheumatol; 2007 May; 34(5):978-86. PubMed ID: 17407218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of a usability evaluation of an emerging laboratory order entry system.
    Peute LW; Jaspers MW
    Int J Med Inform; 2007; 76(2-3):157-68. PubMed ID: 16854617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.